jeudi 7 septembre 2017

Onco Actu du 7 septembre 2017

2.6 Etiologie - Environnement

High Levels of Carcinogen Found in Houston Area After Harvey [NY Times]

3.3 Prévention - Vaccins

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award [NCI]

Lowy: NCI’s intramural program made development of the HPV vaccine possible [The Cancer Letter]

3.6 Prévention - Activité physique

Phys Ed: Fitness May Lower Breast Cancer Risk [NY Times]

4. Dépistage, diagnostic et pronostic

A pen that detects cancerous tissue could help surgeons remove the full tumor [STAT]

5. Traitements

Liver Cancer Patients Can Start with Lower Dose of Chemotherapy and Live Just as Long [Penn Medicine]

5.1 Traitements - Pré-clinique

Repurposing Zika [In the Pipeline]

5.12.4 Immunothérapies - Essais

FDA orders Bristol-Myers’ Opdivo to the sidelines on 3 studies as regulators explore dangers of checkpoint combos [EndPoints]

Bristol-Myers Squibb Provides an Update on Three Opdivo-based Combination Clinical Studies in Multiple Myeloma [BMS]

Bristol-Myers says FDA places partial hold on Opdivo myeloma trials [Reuters]

5.12.5 Immunothérapies - Pharma

Merck, looking to build on cancer success, buys I-O biotech Rigontec [FierceBiotech]

Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal [EndPoints]

5.2 Pharma

Verastem’s low-stakes comeback gamble on an AbbVie/Infinity castoff pays off with positive CLL data [EdnPoints]

Verastem Announces Positive Top-Line Data from the Pivotal Phase 3 DUO Study in Relapsed of Refratory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma [Verastem]

Verastem's blood cancer drug succeeds in late-stage trial [Reuters]

5.2.3 Pharma - économie

NuCana plans $115M IPO to test retooled chemotherapies [FierceBiotech]

5.4 Traitements - Economie

NICE throws a wrench in Takeda's Ninlaro growth plans with second rejection [FiercePharma]

Should Value Frameworks Take A ‘Societal Perspective’? [Health Affairs Blog]

5.6.12 ESMO - Observation

ESMO 2017 Press Release: Some Stroke Survivors May Have Underlying Cancer [ESMO]

Stroke survivors doubly at risk of cancer, scientists warn [The Telegraph]

5.6.2 ESMO - Divers

Keyhole oesophageal cancer surgery as good as more invasive operations [Cancer Research UK]

ESMO 2017 Media Alert: Challenges Faced by Adolescent and Young Adult Cancer Patients: Press Conference at the ESMO 2017 Congress [ESMO]

6.11 Patients

Discussing cancer costs can reduce treatment expenses [Reuters]

6.5 Médecines alternatives

Naturopathic Cancer Quackery [Science-Based Medicine]

6.6 Publications

Predatory publishers ensnare even Ivy League scientists — sometimes at taxpayers’ expense [STAT]

Predatory journals: Not just a problem in developing world countries, says new Nature paper [Retraction Watch]

6.7 DMP, Big Data & applis

IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close [STAT]